Lawyer Overview

Jim Burling is a partner in the firm's Regulatory and Government Affairs and Litigation/Controversy Departments, and a member of the Antitrust and Competition and Intellectual Property Litigation Practice Groups. He joined the firm in 1979.

Mr. Burling previously chaired Hale and Dorr's Executive Committee, Litigation Department and Antitrust Group. He joined the firm after two years with the Federal Trade Commission. While Mr. Burling's principal office is in Boston, he spends considerable time working from the firm's Washington, DC office.

Practice

Mr. Burling concentrates in antitrust litigation and merger clearance for high technology clients, particularly in the computer, Internet, biotech and pharmaceutical industries. His practice includes representing clients in private litigation, in responding to government antitrust investigations, and before the Department of Justice and Federal Trade Commission in Hart-Scott-Rodino (HSR) review of mergers and acquisitions.

Recent Highlights

Litigation

• Defending Ocean Spray Cranberries, Inc. against monopolization claims in D.D.C., District of Massachusetts and California Superior Court
• Defending Avid against monopolization and conspiracy claims in C.D. Cal. and the Ninth Circuit
• Defending IDEXX Laboratories against exclusive dealing claims in D. Conn. and the Second Circuit
• Defending The Open Software Foundation against monopolization and conspiracy claims in D. Mass and the First Circuit
• Defending Analog Devices against exclusive dealing claims in N.D. Cal. and the Ninth Circuit
• Defending Nortel Networks against monopolization and tying claims in D. Mass

Merger Clearance/Government Investigations

• Representing two pharmaceutical companies in separate investigations by the FTC
• Representing an overseas holding company in a number of US and global sales and acquisitions, several involving second request proceedings
• Representing a pharmaceuticals company through second request proceedings reviewing an exclusive license agreement
• Representing Internet company in acquisitions under HSR review

Professional Activities

• Member, American Bar Association (ABA) Antitrust Section
• Former vice-chair, ABA Antitrust Section Intellectual Property Committee
• Fellow, Massachusetts Bar Association
• Member, Boston Bar Association Antitrust Committee

Honors and Awards

• Listed in the 2010 edition of Benchmark Litigation for his leading antitrust practice
• Recognized as a leader in his field in the 2009 edition of Who's Who of Competition Lawyers and Economists
• Recommended as one of the world's leading competition/antitrust attorneys in the PLC Cross-border Competition Handbook 2006/07
• Recognized as a leader in the field of antitrust in each edition of Chambers USA: America's Leading Lawyers for Business since 2003. Described by the Bar as "highly capable" and a "clear leader" in the 2004 edition
• Selected by peers for inclusion in The Best Lawyers in America, in the area of antitrust law (2006, 2008, 2009, 2010). Named by Best Lawyers as Boston Antitrust Lawyer of the Year in 2010
• Named a "New England Super Lawyer" (formerly "Massachusetts Super Lawyer") in antitrust litigation in the 2004, 2005, 2006, 2007, 2008 and 2009 issues of Boston Magazine         

Speaking Engagements

• American Conference Institute Prescription Drug Pricing Seminar – "Litigation Regarding Orange Book Patent Listings" – 2002
• MCLE Criminal Law Conference: Spend A Day With The Experts – "Demonstrative Evidence" – 2001
• MCLE Managing Antitrust Issues: A Practical Guide for In-House and Outside Corporate Counsel – "Managing Antitrust Issues for Joint Ventures" – 1997
• MCLE 30th Annual New England Antitrust Conference – "Antitrust Guidance for The Innovative Enterprise" – 1996
• Antitrust and Tort Limits on Marketplace Rivalry, ABA Section of Antitrust Law – "Special Issues in Competitor Litigation: Expert Witnesses in Litigation Between Competitors" – 1995

Publications

• James C. Burling and Allen C. Nunnally, Litigation Regarding Orange Book Patent Listings, American Conference Institute Prescription Drug Pricing Seminar, 2002.
• James C. Burling and Rebecca J. Lewin, Demonstrative Evidence, MCLE Criminal Law Conference: Spend A Day With The Experts, 2001.
• James C. Burling, William F. Lee, and Anita K. Krug, The Antitrust Duty to Deal and Intellectual Property Rights, 24 J. Corp. L. 527 (1999).
• James C. Burling and Ahavia D. Glaser, Managing Antitrust Issues for Joint Ventures, MCLE Managing Antitrust Issues: A Practical Guide for In-House and Outside Corporate Counsel, 1997.
• Antitrust Guidance for The Innovative Enterprise, MCLE 30th Annual New England Antitrust Conference, 1996.
• DOJ and FTC Antitrust Guidelines for the Licensing of Intellectual Property: Selected Topics, MCLE 30th New England Antitrust Conference, Antitrust Guidance for the Innovative Enterprise, 1996.
• Special Issues in Competitor Litigation: Expert Witnesses in Litigation Between Competitors, Antitrust and Tort Limits on Marketplace Rivalry, ABA Section of Antitrust Law, 1995.
• James C. Burling, William F. Lee, and James L. Quarles, " State Action" Antitrust Immunity – A Doctrine In Search of Definition1982 BYU L. Rev. 809 (1982).

Community Involvement

• Member of the Board of Directors, Center for Public Representation
• Member of the Board of Directors, New England Center for Children

Areas of Practice

• Antitrust and Competition
• Software
• Antitrust Litigation
• Regulatory and Government Affairs
• Litigation/Controversy
• Intellectual Property Litigation

Representative Cases

• Cephalon / Provigil Antitrust
• Conexant Systems / Globespan Virata
• DuPont Merck Pharmaceutical Co. v. Cilag AG , (US District Court for the District of Delaware)
• Rosie D. v. Romney , (US District Court for the District of Massachusetts)

West Practice Categories

Antitrust & Trade Regulation, Antitrust Law

Bar Admissions

• Massachusetts

Education

• Harvard Law School, 1976
  JD
• Grinnell College, 1972
  AB

Published Works

• PharmaBulletin, 2007
• PharmaBulletin, 2006
• PharmaBulletin, 2006
• PharmaBulletin, 2006
• PharmaBulletin, 2005
• Antitrust and Trade Regulation Bulletin, 2003
• FTC Recommends Sweeping Changes in the Balance between Competition and Patent Law, 2003
• Antitrust and Trade Regulation Bulletin, 2003
• Antitrust and Trade Regulation Bulletin, 2002
• Antitrust and Trade Regulation Bulletin, 2002
• Antitrust and Trade Regulation Bulletin, 2002
• Litigation Regarding Orange Book Patent Listings, 2002
• Antitrust and Trade Regulation Bulletin, 2001
• Antitrust and Trade Regulation Bulletin, 2001
• Antitrust and Trade Regulation Bulletin, 2001
• Demonstrative Evidence, 2001
• Demonstrative Evidence, 2001
• Antitrust and Trade Regulation Bulletin, 2000
• Significant Antitrust Issues Posed by Procurement B2B Exchanges, 2000
• Antitrust and Trade Regulation Bulletin, 2000
• Antitrust and the Internet, 1999
• Antitrust and the Internet, 1999
• Antitrust and Trade Regulation Bulletin, 1999
• Antitrust and Trade Regulation Bulletin, 1999
• The Antitrust Duty to Deal and Intellectual Property Rights, 1999
• Antitrust and Trade Regulation Bulletin, 1998
• Antitrust and Trade Regulation Bulletin, 1997
• Managing Antitrust Issues for Joint Ventures, 1997
• Antitrust Guidance for The Innovative Enterprise, 1996
• DOJ and FTC Antitrust Guidelines for the Licensing of Intellectual Property: Selected Topics, 1996
• Antitrust and Trade Regulation Bulletin, 1995
• Special Issues in Competitor Litigation: Expert Witnesses in Litigation Between Competitors, 1995
• State Action Antitrust Immunity – A Doctrine In Search of Definition, 1982

Address

60 State Street
Boston, MA 02109

Phones

+1 617 526 6416 (Business Phone)

Faxes

+1 617 526 5000 (Business Fax)

Emails

Contact Us (Business Email)

Websites

www.wilmerhale.com